Modern Care Journal

Published by: Kowsar

The Prevalence and Risk Factors of Type II Diabetes Mellitus Among Patients with Hepatitis B Virus: A Descriptive Correlational Study

Masood Ziaee 1 , Gholamreza Sharifzadeh 1 , Zohreh Azarkar 1 , Mohammad Hasan Namaei 1 , Mahmood Zardast 1 , Mahboubeh Saljoughi 2 , Samira Elhamirad 3 and Azadeh Ebrahimzadeh 1 , *
Authors Information
1 Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 MSc Clinical Psychology, Sabzevar University of Medical Sciences, Sabzevar, Iran
3 Department of Health Services Management, Faculty of Health, Zabol University of Medical Sciences, Zabol, Iran
Article information
  • Modern Care Journal: April 2017, 14 (2); e65664
  • Published Online: April 24, 2017
  • Article Type: Research Article
  • Received: March 2, 2017
  • Accepted: March 4, 2017
  • DOI: 10.5812/modernc.65664

To Cite: Ziaee M, Sharifzadeh G, Azarkar Z, Namaei M H, Zardast M, et al. The Prevalence and Risk Factors of Type II Diabetes Mellitus Among Patients with Hepatitis B Virus: A Descriptive Correlational Study, Mod Care J. 2017 ; 14(2):e65664. doi: 10.5812/modernc.65664.

Abstract
Copyright © 2017, Modern Care Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
References
  • 1. Ephraim R, Nsiah P, Osakunor D, Adoba P, Sakyi S, Anto E. Seroprevalence of Hepatitis B and C Viral Infections among Type 2 Diabetics: A Cross-sectional Study in the Cape Coast Metropolis. Ann Med Health Sci Res. 2014;4(5):719-22. doi: 10.4103/2141-9248.141529. [PubMed: 25328781].
  • 2. Deshpande G, Klink AJ, Shenolikar R, Singer J, Eisenberg Lawrence DF, Krishnarajah G. Economic burden of hepatitis B infection among patients with diabetes. Hum Vaccin Immunother. 2016;12(5):1132-40. doi: 10.1080/21645515.2015.1127488. [PubMed: 27050021].
  • 3. Lavanchy D, Kane M. Hepatitis B virus in human diseases. In: Liaw YF, Zoulim F, editors. Germany: Springer; 2016. Global epidemiology of hepatitis B virus infection; p. 187-203.
  • 4. Chen HF, Li CY, Chen P, See TT, Lee HY. Seroprevalence of hepatitis B and C in type 2 diabetic patients. J Chin Med Assoc. 2006;69(4):146-52. doi: 10.1016/S1726-4901(09)70195-9. [PubMed: 16689194].
  • 5. Ziaee M, Ebrahimzadeh A, Azarkar Z, Namaei MH, Saburi A, Fereidouni M, et al. Seroprevalence and risk factors for hepatitis B in an adult population, the first report from Birjand, south Khorasan, Iran. Hepat Mon. 2016;16(9):36452. doi: 10.5812/hepatmon.36452. [PubMed: 27822260].
  • 6. Kazemi T, Rezvani MR, Sharifzadeh GR, Sadri A, Moghaddam M, Reza H. The prevalence of traditional cardiovascular risk factors in low socioeconomic use individuals in Birjand 2008, (East IRAN). J Cardiothorac Med. 2015;3(1):263-9.
  • 7. Cai C, Zeng J, Wu H, Shi R, Wei M, Gao Y, et al. Association between hepatitis B virus infection and diabetes mellitus, A meta analysis. Exp Ther Med. 2015;10(2):693-8. doi: 10.3892/etm.2015.2537. [PubMed: 26622377].
  • 8. Garcia Compean D, Gonzalez Gonzalez JA, Lavalle Gonzalez FJ, Gonzalez Moreno EI, Villarreal Perez JZ, Maldonado Garza HJ. Current concepts in diabetes mellitus and chronic liver disease, clinical outcomes, hepatitis c virus association, and therapy. Dig Dis Sci. 2016;61(2):371-80. doi: 10.1007/s10620-015-3907-2. [PubMed: 26462490].
  • 9. Han H, Deng H, Han T, Zhao H, Hou F, Qi X. Association between hepatocellular carcinoma and type 2 diabetes mellitus in Chinese hepatitis B virus cirrhosis patients, a case control study. Med Sci Monit. 2017;23:3324-34. [PubMed: 28689209].
  • 10. Li M, Zhou H, Guan Y, Peng H, Wang S, Zhang P, et al. Positive hepatitis B surface antibody is associated with reduced risk of diabetes mellitus in retired female Chinese workers. J Diabetes. 2016;8(1):158-61. doi: 10.1111/1753-0407.12317. [PubMed: 26016384].
  • 11. Memon MS, Arain ZI, Naz F, Zaki M, Kumar S, Burney AA. Prevalence of type 2 diabetes mellitus in hepatitis C virus infected population: a Southeast Asian study. J Diabetes Res. 2013;2013:539361. doi: 10.1155/2013/539361. [PubMed: 23984431].
  • 12. Aghamohammadzadeh N, Ghotaslou R, Javadi M, Najafipour F, Niafar M. Prevalence of hepatitis C infection among type 2 diabetic patients. Med J Tabriz Univ Med Sci Health Serv. 2010;32(5).
  • 13. Antonelli A, Ferri C, Fallahi P, Pampana A, Ferrari SM, Goglia F, et al. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care. 2005;28(10):2548-50. [PubMed: 16186298].
  • 14. Gisi K, Cetinkaya A, Ozkaya M, Kantarceken B, Gisi G, Koroglu S. Hepatitis B and C seroprevalence in patients with diabetes mellitus and its relationship with microvascular complications. Prz Gastroenterol. 2017;12(2):105-10. doi: 10.5114/pg.2016.64748. [PubMed: 28702098].
  • 15. Jadoon NA, Shahzad MA, Yaqoob R, Hussain M, Ali N. Seroprevalence of hepatitis C in type 2 diabetes: evidence for a positive association. Virol J. 2010;7:304. doi: 10.1186/1743-422X-7-304. [PubMed: 21054842].
  • 16. Huang J, Ou HY, Lin J, Karnchanasorn R, Feng W, Samoa R, et al. The impact of hepatitis B vaccination status on the risk of diabetes, implicating diabetes risk reduction by successful vaccination. PLoS One. 2015;10(10):139730. doi: 10.1371/journal.pone.0139730. [PubMed: 26509504].
  • 17. Liu TL, Trogdon J, Weinberger M, Fried B, Barritt AS. Diabetes is associated with clinical decompensation events in patients with cirrhosis. Dig Dis Sci. 2016;61(11):3335-45. doi: 10.1007/s10620-016-4261-8. [PubMed: 27480088].
  • 18. Lu J, Hou X, Tu H, Tang Z, Xiang Y, Bao Y, et al. Chronic hepatitis B virus infection status is more prevalent in patients with type 2 diabetes. J Diabetes Investig. 2017;8(4):619-25. doi: 10.1111/jdi.12609. [PubMed: 27930871].
  • 19. Fu SC, Huang YW, Wang TC, Hu JT, Chen DS, Yang SS. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study. Aliment Pharmacol Ther. 2015;41(11):1200-9. doi: 10.1111/apt.13191. [PubMed: 25846548].
  • 20. Petit JM, Hamza S, Rollot F, Sigonney V, Crevisy E, Duvillard L, et al. Impact of liver disease severity and etiology on the occurrence of diabetes mellitus in patients with liver cirrhosis. Acta Diabetol. 2014;51(3):455-60. doi: 10.1007/s00592-013-0538-y. [PubMed: 24352343].
  • 21. Mekonnen D, Gebre-Selassie S, Fantaw S, Hunegnaw A, Mihret A. Prevalence of hepatitis B virus in patients with diabetes mellitus: a comparative cross sectional study at Woldiya General Hospital, Ethiopia. Pan Afr Med J. 2014;17:40. doi: 10.11604/pamj.2014.17.40.2465. [PubMed: 24932351].
  • 22. Cefalu W, American Diabetes A. Classification and diagnosis of diabetes, american diabetes, association. Diabetes Care. 2016;39(1):13-22. doi: 10.2337/dc16-S005. [PubMed: 26696675].
  • 23. Spradling PR, Simons B, Narayanan M, Xing J, Homan C, Bulkow L, et al. Incidence of diabetes mellitus in a population-based cohort of persons with chronic hepatitis B virus infection. J Viral Hepat. 2013;20(7):510-3. doi: 10.1111/jvh.12071. [PubMed: 23730845].
  • 24. Soverini V, Persico M, Bugianesi E, Forlani G, Salamone F, Massarone M, et al. HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areas. Acta Diabetol. 2011;48(4):337-43. doi: 10.1007/s00592-011-0293-x. [PubMed: 21574001].
  • 25. Schillie SF, Xing J, Murphy TV, Hu DJ. Prevalence of hepatitis B virus infection among persons with diagnosed diabetes mellitus in the United States, 1999-2010. J Viral Hepat. 2012;19(9):674-6. doi: 10.1111/j.1365-2893.2012.01616.x. [PubMed: 22863272].
  • 26. Arrelias CC, Bellissimo-Rodrigues F, Lima LC, Silva AS, Lima NK, Zanetti ML. Hepatitis B vaccination coverage in patients with diabetes mellitus. Rev Esc Enferm USP. 2016;50(2):255-62. doi: 10.1590/S0080-623420160000200011. [PubMed: 27384205].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments